TGF-β inhibitors for the treatment of cancer

被引：65
|
作者：
Lahn, M [1 ]
Kloeker, S [1 ]
Berry, BS [1 ]
机构：
[1] Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Therapeut Area Oncol, Indianapolis, IN 46285 USA
来源：
EXPERT OPINION ON INVESTIGATIONAL DRUGS | 2005年 / 14卷 / 06期
关键词：
antisense oligonucleotide; cancer; clinical Studies; knockout mice; monoclonal antibodies; TGF-beta; TGF-beta RI kinase inhibitors;
D O I：
10.1517/13543784.14.6.629
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Advances in understanding the role of transforming growth factor (TGF)-beta in tumorigenesis have led to the development of TGF-beta inhibitors for cancer treatment. Three platforms of TGF-beta inhibitors have evolved: antisense oligonucleotides, monoclonal antibodies and small molecules. in this review, the current stage of development of each known TGF-beta inhibitor will be discussed. As part of the risk/benefit assessment of TGF-beta inhibitors, the known effects of TGF-beta deficiency in mice, non-clinical toxicology studies with TGF-beta inhibitors in rats, and the clinical studies with monoclonal antibodies against TGF-beta will be summarised.
引用
收藏
页码：629 / 641
页数：13
相关论文
共 50 条
  • [1] A Perspective on the Development of TGF-β Inhibitors for Cancer Treatment
    Huynh, Linh Khanh
    Hipolito, Christopher John
    ten Dijke, Peter
    BIOMOLECULES, 2019, 9 (11)
  • [2] TGF-β and cancer
    Bierie, B
    Moses, HL
    CYTOKINE & GROWTH FACTOR REVIEWS, 2006, 17 (1-2) : 29 - 40
  • [3] TGF-β and cancer
    Reiss, M
    MICROBES AND INFECTION, 1999, 1 (15) : 1327 - 1347
  • [4] TGF-β signaling in cancer
    Gu, Shuchen
    Feng, Xin-Hua
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2018, 50 (10) : 941 - 949
  • [5] Inhibitors of the TGF-β superfamily and their clinical applications
    Tsuchida, K.
    Sunada, Y.
    Noji, S.
    Murakami, T.
    Uezumi, A.
    Nakatani, M.
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2006, 6 (11) : 1255 - 1261
  • [6] Overlapping activities of TGF-β and Hedgehog signaling in cancer: Therapeutic targets for cancer treatment
    Perrot, Carole Y.
    Javelaud, Delphine
    Mauviel, Alain
    PHARMACOLOGY & THERAPEUTICS, 2013, 137 (02) : 183 - 199
  • [7] TGF- Inhibitors in Metastatic Pancreatic Ductal Adenocarcinoma
    Alvarez, Marcus A.
    Freitas, Julia Pedo
    Hussain, S. Mazher
    Glazer, Evan S.
    JOURNAL OF GASTROINTESTINAL CANCER, 2019, 50 (02) : 207 - 213
  • [8] Targeting TGF-β signaling in cancer
    Katz, Lior H.
    Li, Ying
    Chen, Jiun-Sheng
    Munoz, Nina M.
    Majumdar, Avijit
    Chen, Jian
    Mishra, Lopa
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2013, 17 (07) : 743 - 760
  • [9] TGF-β signaling in cancer metastasis
    Xie, Feng
    Ling, Li
    van Dam, Hans
    Zhou, Fangfang
    Zhang, Long
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2018, 50 (01) : 121 - 132
  • [10] The dynamic roles of TGF-β in cancer
    Meulmeester, Erik
    ten Dijke, Peter
    JOURNAL OF PATHOLOGY, 2011, 223 (02) : 205 - 218
12345